SCHEMBL17479217

SCHEMBL17479217

Cc1cc(O)nc2ccc(NC(=O)c3cc(C(N)=O)ccc3N3CCOCC3)cc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 5/20 0.52
MAPT P10636 6/20 0.50
LMNA P02545 2/20 0.50
TP53 P04637 1/20 0.50
MAPK1 P28482 1/20 0.50
RAB9A P51151 1/20 0.50
ALDH1A1 P00352 8/20 0.49
KDM4E B2RXH2 5/20 0.49
HPGD P15428 2/20 0.49
HSD17B10 Q99714 2/20 0.49
HTT P42858 2/20 0.48
GLA P06280 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
ITGA4 P13612 2/20 0.47
MITF O75030 1/20 0.47
G6PD P11413 1/20 0.47
ALOX12 P18054 1/20 0.47
MC4R P32245 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
TLR9 Q9NR96 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17479103 0.93 GBA1 (0.54) GBA1MAPTLMNATP53MAPK1
SCHEMBL17478935 0.93 GBA1 (0.54) GBA1MAPTLMNATP53MAPK1
SCHEMBL17478665 0.90 GBA1 (0.51) GBA1MAPTLMNATP53MAPK1
SCHEMBL19667060 0.90 GBA1 (0.53) GBA1MAPTLMNATP53MAPK1
SCHEMBL17478615 0.89 GBA1 (0.52) GBA1MAPTLMNATP53MAPK1
SCHEMBL17479091 0.88 ALDH1A1 (0.63) GBA1MAPTLMNATP53MAPK1
SCHEMBL17479284 0.87 GBA1 (0.52) GBA1MAPTLMNATP53MAPK1
SCHEMBL17478823 0.87 GBA1 (0.52) GBA1MAPTLMNATP53MAPK1
SCHEMBL19667063 0.87 GBA1 (0.49) GBA1MAPTLMNATP53MAPK1
SCHEMBL17478793 0.87 ALDH1A1 (0.49) GBA1MAPTLMNATP53MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3174868-A1 COMPOUNDS ACTIVE TOWARDS BROMODOMAINS Nuevolution A/S (DK) 2017-06-07 EP claimed
WO-2016016316-A1 COMPOUNDS ACTIVE TOWARDS BROMODOMAINS NUEVOLUTION A/S (DK) 2016-02-04 WO claimed
US-20170349607-A1 COMPOUNDS ACTIVE TOWARDS BROMODOMAINS NUEVOLUTION A/S (DK) 2017-12-07 US disclosed
US-20170349607-A1 COMPOUNDS ACTIVE TOWARDS BROMODOMAINS NUEVOLUTION A/S (DK) 2017-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170349607-A1 COMPOUNDS ACTIVE TOWARDS BROMODOMAINS BRD4, BRD3, BRDT GBA1 1736/4885MAPT 575/4885LMNA 1289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.